Moneycontrol
HomeNewsIndiaN440K coronavirus strain not new, is fading away now, say CCMB scientists

N440K coronavirus strain not new, is fading away now, say CCMB scientists

Dismissing media reports that the N440K variant is responsible for the second wave, CCMB scientists have said the B1617 strain is dominating in most parts of the country.

May 05, 2021 / 15:48 IST
Story continues below Advertisement
Rerpresentative image

The Centre for Cellular and Molecular Biology (CCMB) has dismissed reports that N440K variant of the SARS-CoV-2  was responsible for the second wave of coronavirus that has led to a record surge in infections and death in India.

The N440K, which had wreaked havoc in Southern India in 2020, was fading away, the Hyderabad-based life sciences facility said on May 5.  Divya Tej Sowpati, a scientist at the CCMB, tweeted: “The N440K variant of SARS-CoV-2 is diminishing and is likely to disappear soon.”

Though N440K was of particular concern in South India during and after the coronavirus first wave, at present, it was being replaced by the B1617 and B117 variants, Sowpati said.

The prevalence of the N440K coronavirus variant was very low in Andhra Pradesh. “It is there in less than five percent of the samples. It is incorrect to say it is causing havoc. The B1617 variant is dominating now in most parts of the country,” the scientist said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show